Corporate Venture Capital's growing role and importance in HealthTech
Lloyd Price
DECEMBER 7, 2023
Merck Ventures: Merck Ventures has invested in a range of healthtech startups, including Clue, GlycoMimetics, and AbCellera, demonstrating its interest in areas such as women's health, oncology, and immunotherapy. In 2021, Omada Health was acquired by UnitedHealth Group for $5 billion. The company has raised over $1.3
Let's personalize your content